Adversity Index for Clinical Trials: An Inclusive Approach for Analysis of Safety Data
This paper proposes a new method for analysis of adverse event data in clinical trials. The method is illustrated by application to data on 4 phase III clinical trials, two on breast cancer and two on diabetes mellitus.
READ FULL TEXT